This morning's Indian Express op-ed page carries my views on the impact of the Ranbaxy revelations on Indian generics. To read click here. Just to clarify, I had attributed numbers on US imports of bulk drugs and finished medicines that I have cited in the column to Fortune magazine. The attribution appears to have fallen … Continue reading The Ranbaxy effect : My op-ed in The Indian Express
Apothecurry 